Baird raised the firm’s price target on HCA Healthcare (HCA) to $423 from $380 and keeps a Neutral rating on the shares. The firm adjusted the price target after updating its power rankings in managed care and healthcare facilities.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare’s Earnings Call: Strong Growth Amid Challenges
- HCA Healthcare price target lowered to $400 from $410 at Morgan Stanley
- HCA Healthcare price target raised to $380 from $361 at TD Cowen
- HCA Healthcare price target lowered to $401 from $404 at RBC Capital
- HCA Healthcare: Hold Rating Amid Mixed Signals and Policy Uncertainty